Gregory Perry
Director of Finance/CFO bei MERUS N.V.
Vermögen: - $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mark Iwicki | M | 57 | 9 Jahre | |
| Bill Lundberg | M | 60 | 5 Jahre | |
| Peter Silverman | M | 46 | 7 Jahre | |
| Howard Rosen | M | 66 | 10 Jahre | |
| Susan Graf | F | 52 | 3 Jahre | |
| Chris W. Shumway | M | 58 | 4 Jahre | |
| Mary Reumuth | F | 48 | 10 Jahre | |
| Eric Trachtenberg | M | 51 | 6 Jahre | |
| Anand Mehra | M | 48 | 9 Jahre | |
| Andrew Koven | M | 66 | 7 Jahre | |
| Joseph J. Kenny | M | - | 15 Jahre | |
| Todd Bazemore | M | 53 | 7 Jahre | |
| Victor Sandor | M | 57 | 5 Jahre | |
| Sherri L. Spear | F | - | - | |
| Marjan Farid | M | 50 | 2 Jahre | |
| Theresa Wingrove | M | 66 | 13 Jahre | |
| Mark Blumenkranz | M | 73 | 3 Jahre | |
| Charles Myers | M | 70 | 3 Jahre | |
| Domenic J. Ferrante | M | 58 | 5 Jahre | |
| Paolo Pucci | M | 63 | 4 Jahre | |
| Len Kanavy | M | 62 | 6 Jahre | |
| Ashley Pereira | M | - | 3 Jahre | |
| Shannon Campbell | F | - | 2 Jahre | |
| Cecilia Anna Wilhelmina Geuijen | M | 56 | 3 Jahre | |
| Kathleen Farren | F | - | - | |
| Andrew Joe | M | 58 | 4 Jahre | |
| Ernesto Wasserman | M | - | 8 Jahre | |
| Alexander Berthold Hendrik Bakker | M | 57 | 14 Jahre | |
| Harry Shuman | M | - | - | |
| Hannah Deresiewicz | F | - | - | |
| Liu Hui | M | 51 | 9 Jahre | |
| John Heffernan | M | - | 9 Jahre | |
| Maxine Gowen | M | 66 | 3 Jahre | |
| Darius Kharabi | M | 45 | 3 Jahre | |
| John de Kruif | M | 60 | 17 Jahre | |
| Romulus Brazzell | M | 71 | 11 Jahre | |
| Matthew Nelson | M | - | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Christopher McNulty | M | 47 | 5 Jahre | |
| Ton Logtenberg | M | 65 | 16 Jahre | |
| Mitchel Sayare | M | 76 | 25 Jahre | |
| Gary H. Rabin | M | 58 | 7 Jahre | |
| Mary Szela | F | 60 | 1 Jahre | |
| Robert Langer | M | 75 | 9 Jahre | |
| Donald Stern | M | 78 | 4 Jahre | |
| Andrew Noh | M | - | 4 Jahre | |
| Masao Yoshida | M | - | - | |
| Jay Duker | M | 66 | 8 Jahre | |
| Michael Heffernan | M | 59 | 4 Jahre | |
| Marc Blaustein | M | 61 | 2 Jahre | |
| Paul Wotton | M | 63 | 2 Jahre | |
| Marc Beer | M | 59 | 5 Jahre | |
| Wendy Dixon | M | 68 | 6 Jahre | |
| Edward Myles | M | 52 | 3 Jahre | |
| Michael Dennis Price | M | 66 | 3 Jahre | |
| William Heiden | M | 64 |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | 4 Jahre |
| Paulina Hill | M | 42 | 1 Jahre | |
| Jeffrey Hackman | M | 62 | 1 Jahre | |
| Samuel Hamood | M | 56 | - | |
| Mary Weger | F | 65 | - | |
| Linda Friedman | F | - | - | |
| Cameron Wheeler | M | 45 | - | |
| Nicholas Haft | M | 35 | 3 Jahre | |
| Joseph Vittiglio | M | 52 | 2 Jahre | |
| William T. Andrews | M | 60 | 4 Jahre | |
| Barry Gertz | M | 72 | - | |
| Zain Kassam | M | 42 | 4 Jahre | |
| Mark Throsby | M | 57 | 12 Jahre | |
| Ben Harshbarger | M | 55 | 4 Jahre | |
| Joanne Viney | M | 58 | - | |
| Remi A. Menes | M | - | 1 Jahre | |
| Sarah Kiely | F | - | 7 Jahre | |
| Mark Dipaolo | M | 53 | 1 Jahre | |
| Jillian Connell | F | - | - | |
| David Warren Carter | M | 84 | 14 Jahre | |
| Tamara Joseph | F | 61 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 1 Jahre |
| Kristine Peterson | F | 64 | 12 Jahre | |
| Howard H. Pien | M | 66 | 9 Jahre | |
| Dean Mitchell | M | 68 | 12 Jahre | |
| Paul Chaney | M | 66 | 4 Jahre | |
| Zohar Loshitzer | M | 67 | 5 Jahre | |
| Anne Cook | F | 62 | 4 Jahre | |
| Suzanne Bruhn | M | 60 | 3 Jahre | |
| Mark Levin | M | 73 | 6 Jahre | |
| Robert Tepper | M | 68 | 9 Jahre | |
| Doug Treco Treco | M | 66 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 17 Jahre |
| Noubar Afeyan | M | 60 | 6 Jahre | |
| Alan C. Shapiro | M | 78 | 11 Jahre | |
| Mark Goldberg | M | 69 | 13 Jahre | |
| Mark Corrigan | M | 66 | 2 Jahre | |
| Robert Paull | M | 47 | - | |
| Suzanne M. Cadden | F | 64 | - | |
| Raj Shah | M | 46 | 6 Jahre | |
| Kevin Kotler | M | 53 | 2 Jahre | |
| Lionel Carnot | M | 56 | 8 Jahre | |
| David J. Aubuchon | M | - | - | |
| Gregory Grunberg | M | 51 | 7 Jahre | |
| John Paul de Koning | M | 55 | 10 Jahre | |
| Anne Marie Conway | F | - | - | |
| Peter J. Williams | M | 69 | 8 Jahre | |
| Susan L. Coultas | M | - | 6 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 71 | 71,00% |
| Niederlande | 24 | 24,00% |
| Kanada | 9 | 9,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Gregory Perry
- Persönliches Netzwerk
